NDC 0003-3641

EVOTAZ

Atazanavir And Cobicistat

EVOTAZ is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Atazanavir Sulfate; Cobicistat.

Product ID0003-3641_0c387928-de94-40d6-b1d7-cfeed3801cbd
NDC0003-3641
Product TypeHuman Prescription Drug
Proprietary NameEVOTAZ
Generic NameAtazanavir And Cobicistat
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-01-29
Marketing CategoryNDA / NDA
Application NumberNDA206353
Labeler NameE.R. Squibb & Sons, L.L.C.
Substance NameATAZANAVIR SULFATE; COBICISTAT
Active Ingredient Strength300 mg/1; mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0003-3641-11

30 TABLET in 1 BOTTLE (0003-3641-11)
Marketing Start Date2015-01-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0003-3641-11 [00003364111]

EVOTAZ TABLET
Marketing CategoryNDA
Application NumberNDA206353
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-01-29

Drug Details

Active Ingredients

IngredientStrength
ATAZANAVIR SULFATE300 mg/1

OpenFDA Data

SPL SET ID:83db29d7-5d85-49d6-8cb6-740473365cf8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1601654
  • 1601660
  • UPC Code
  • 0300000000001
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitor [EPC]
    • P-Glycoprotein Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
    • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]

    NDC Crossover Matching brand name "EVOTAZ" or generic name "Atazanavir And Cobicistat"

    NDCBrand NameGeneric Name
    0003-3641EVOTAZatazanavir and cobicistat
    50090-1724EVOTAZatazanavir and cobicistat

    Trademark Results [EVOTAZ]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EVOTAZ
    EVOTAZ
    86092023 4765196 Live/Registered
    Bristol-Myers Squibb Company
    2013-10-15

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.